Abiomed Revenue Y/Y
What is the Revenue Y/Y of Abiomed?
The Revenue Y/Y of Abiomed Inc. is 10.32%
What is the definition of Revenue Y/Y?
Yearly revenue growth is the percentage growth of the company’s revenue over trailing twelve months.
= (revenue past four quarters - revenue previous four quarters) / revenue previous four quarters
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Revenue Y/Y of companies in the Health Care sector on NASDAQ compared to Abiomed
What does Abiomed do?
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Companies with revenue y/y similar to Abiomed
- Primary Health Properties Plc has Revenue Y/Y of 10.30%
- John Wiley & Sons has Revenue Y/Y of 10.30%
- PVA TePla AG has Revenue Y/Y of 10.30%
- PVA TePla AG has Revenue Y/Y of 10.30%
- Saputo has Revenue Y/Y of 10.30%
- BWP Trust has Revenue Y/Y of 10.31%
- Abiomed has Revenue Y/Y of 10.32%
- cmlog has Revenue Y/Y of 10.32%
- Commvault Systems Inc has Revenue Y/Y of 10.32%
- Ipsen SA has Revenue Y/Y of 10.33%
- United Fire Inc has Revenue Y/Y of 10.34%
- Hilton World.Hdgs Dl ,01 has Revenue Y/Y of 10.34%
- Ameresco has Revenue Y/Y of 10.34%